Wal-D3

Quick links to important sections

Wal-D3

Medically reviewed

Marina Burgos

Last updated on 22/12/2025

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Wal-D3

Understanding Wal-D3

Wal-D3 is a nutritional supplement that contains Cholecalciferol, commonly known as Vitamin D3. Vitamin D is a fat-soluble vitamin that plays a fundamental role in several physiological processes within the human body. While the body can synthesize Vitamin D through direct exposure to sunlight, various factors such as geography, lifestyle, and skin pigmentation can lead to insufficient levels, necessitating supplementation.

Composition and Mechanism

The active ingredient, Vitamin D3, is the naturally occurring form of Vitamin D that the body produces when skin is exposed to ultraviolet B (UVB) rays. Once ingested or synthesized, it undergoes two hydroxylations in the body—first in the liver and then in the kidneys—to become the active hormone calcitriol.

Primary Functions

Wal-D3 serves several critical functions in maintaining systemic health:

  • Calcium Absorption: The primary role of Vitamin D3 is to facilitate the absorption of calcium and phosphorus from the gastrointestinal tract. This process is essential for the development and maintenance of bone mineral density.
  • Bone Health: By regulating calcium levels, Vitamin D3 supports the structural integrity of the skeletal system, helping to maintain strong bones and teeth throughout different life stages.
  • Immune System Support: Vitamin D receptors are present on various immune cells, and the vitamin contributes to the modulation of both innate and adaptive immune responses.
  • Neuromuscular Function: It plays a role in muscle function and balance, which is vital for physical stability and coordination.

Use Cases

Wal-D3 is utilized to address or prevent Vitamin D deficiency. This deficiency may manifest in various ways, often affecting bone density and overall physical resilience. Supplementation is frequently used in populations at higher risk of low vitamin levels, including older adults, individuals with limited sun exposure, and those with specific dietary restrictions or malabsorption issues.

Regulatory References

  1. calcium and phosphate homeostasis

What side effects are possible with Wal-D3?

Possible Side Effects and Safety Information

The safety profile for Wal-D3 (Colecalciferol) is defined by its role in mineral regulation, with documented adverse reactions primarily concerning the potential for systemic calcium imbalance and toxicity, especially with excessive intake.

Regulatory documents classify the most relevant adverse effects based on frequency:

  • Uncommon (affecting 1 to 10 users in 1,000): Hypercalcaemia (elevated blood calcium) and Hypercalciuria (elevated urinary calcium).
  • Rare (affecting 1 to 10 users in 10,000): Hypersensitivity reactions, including Pruritus (itching), Rash, and Urticaria (hives).

These effects are grouped into System-Organ Classes, predominantly Metabolism and Nutrition Disorders and Renal and Urinary Disorders, reflecting the compound's physiological role.

Serious Reactions and Safety Restrictions

The most clinically significant adverse reactions documented in official labeling are complications arising from sustained high calcium levels, which may include Renal Calculi (kidney stones) and Nephrocalcinosis. These serious effects are generally associated with long-term exposure to doses above official limits, leading to accumulation.

Use of Wal-D3 is subject to specific regulatory restrictions and is contraindicated in individuals with pre-existing conditions that increase calcium risk, such as Hypercalcaemia, Hypercalciuria, Nephrolithiasis (kidney stones), or existing Hypervitaminosis D. Special safety monitoring is required for patients with renal impairment or conditions like sarcoidosis, as their capacity to metabolize the compound may be altered. This official safety framework focuses on preventing toxicity and accumulation.

Overdose and Emergency Response

Wal-D3 Overdose and when to seek help

Overdose of Wal-D3 (Colecalciferol) results in the condition known as Hypervitaminosis D, which is primarily characterized by elevated calcium levels in the blood (Hypercalcemia). Documented overdose manifestations affect several physiological systems.

Signs listed in regulatory labeling often include a cluster of gastrointestinal, renal, and systemic symptoms:

  • Anorexia, Nausea, Vomiting, Constipation
  • Polyuria (frequent urination), Polydipsia (increased thirst), Dehydration
  • Muscle weakness, Fatigue, Lethargy, Confusion

When to Seek Urgent Help

The regulatory guidance mandates the immediate discontinuation of Wal-D3 upon recognition of any signs of toxicity. Patients must seek immediate medical attention or contact emergency services if severe symptoms develop, particularly those indicating critical organ effects.

Severe or life-threatening outcomes documented in official sources include irreversible renal failure, cardiac arrhythmias, and generalized metastatic calcifications. Management is supportive, as no specific antidote is known. Treatment involves procedures such as intravenous hydration and requires frequent monitoring of serum calcium and renal function in a healthcare setting.

Therapeutic Uses of Wal-D3

What Wal-D3 Treats: Main Uses and Benefits

Wal-D3 (Colecalciferol) is commonly used to help manage conditions associated with systemic imbalance that may result in weakened skeletal structure. It is applied across domains where additional symptomatic support is needed to address the resulting bone weakening, such as Rickets in children and Osteomalacia in adults. The medication is also commonly used to help with supporting bone health alongside other prescribed treatments for conditions like Osteoporosis in adults. This application provides support that helps ease the overall symptom burden and contributes to maintaining a sense of stability.

The medication is applied in addressing symptom clusters related to physical discomfort and functional strain, such as muscle weakness, bone pain, and fatigue associated with deficiency. This is relevant when supportive symptom management is appropriate and contributes to maintaining a sense of functional stability when symptoms are more noticeable. Wal-D3 is generally used for nutritional repletion in specific populations prone to deficiency, including infants, older adults, and those with malabsorption issues.

“The primary therapeutic role is focused on supportive symptom management to help patients cope more steadily with the manifestations of deficiency, particularly those affecting bone health and muscle activity.”


Quick Fact: Relief for Musculoskeletal Strain
Wal-D3 is commonly used to help with managing functional strain and is relevant for easing symptoms related to muscle weakness and skeletal discomfort associated with low Vitamin D levels.

Regulatory References

  1. NIH MedlinePlus overview

Eligibility and Restrictions for Use

Wal-D3 (Colecalciferol) eligibility is defined by regulatory criteria that establish absolute contraindications and mandatory restrictions. Use is strictly contraindicated for any individual with high levels of calcium (Hypercalcaemia or Hypercalciuria) or high Vitamin D (Hypervitaminosis D), as documented in official prescribing information. The medicine must also not be used by patients with a known hypersensitivity to the active substance or in cases of Severe Renal Impairment. Use is generally established and permitted for standard supplementation in adults, adolescents, and children. However, certain high-strength formulations are not recommended for the pediatric population, including children under 12 years. Individuals with conditions like Sarcoidosis or certain chronic kidney conditions must use Wal-D3 only with caution and close monitoring due to altered metabolism or risk of mineral imbalance. Regarding reproductive health, standard supplemental doses are generally recommended during both pregnancy and lactation to address deficiency, but high therapeutic doses are typically not recommended unless clinically essential.

What should I know about interactions with other medicines?

Interactions with other medicines and products

The official regulatory documents define the interaction profile of Wal-D3 (Colecalciferol) based on how other substances interfere with its absorption or create additive effects on mineral levels.

Category Official Regulatory Documentation
Medicinal product categories with documented interactions: Anticonvulsants (enzyme inducers), Bile Acid Sequestrants, Corticosteroids, Thiazide Diuretics, Cardiac Glycosides, Other Vitamin D Analogs, Aluminum-Containing Antacids.
Mechanistic basis of interactions (only if stated in label): Increased catabolism of Colecalciferol, Reduced systemic absorption, Additive effect on calcium homeostasis leading to hypercalcemia.
Timing-based interaction rules (if applicable): Required separation of administration for bile acid sequestrants and aluminum-containing antacids to mitigate the reduction in Colecalciferol absorption.
Population-specific interaction notes (if applicable): Heightened caution for patients with renal impairment (risk of increased aluminum absorption) and patients receiving cardiac glycosides.
Interaction-related restrictions: Co-administration with other Vitamin D metabolites or analogs (such as Calcipotriene) is restricted due to the combined risk of severe hypercalcemia.

Official Interaction Statements

  • Anticonvulsants, including Phenytoin and Phenobarbital, are documented to accelerate Colecalciferol's metabolic breakdown, which results in a reduced systemic effect.
  • The co-administration of Thiazide Diuretics increases the risk of hypercalcemia, stemming from the additive effect on mineral balance.
  • Cardiac Glycosides, such as Digoxin, require heightened caution due to the documented risk that hypercalcemia may enhance the potential for fatal arrhythmias.
  • Substances like bile acid sequestrants (Cholestyramine) and the medicine Orlistat are officially stated to reduce systemic absorption and require dose separation.

Connection to the overall interaction profile

Regulatory documents structure the Wal-D3 interaction profile around its dependency on fat absorption and its direct involvement in calcium regulation. This defines the constraint that substances hindering fat absorption must be taken separately, and it dictates the need for caution with products that pose a risk of hypercalcemia. Official restrictions prohibit combination with other Vitamin D metabolites due to the documented risk of toxicity.

Mechanism of Action

Wal-D3 (Colecalciferol) acts as an essential prohormone that regulates the body's mineral homeostasis through a slow, genomic mechanism, rather than through direct, rapid receptor activation.

Endocrine Activation and Nuclear Receptor Signaling

Colecalciferol must first be hydroxylated by specific enzymes in the liver (25 -hydroxylase) and kidney (1alpha -hydroxylase) to yield the active hormone, Calcitriol (1,25( OH)2 D3). This active form functions as a ligand that binds to the Vitamin D Receptor (VDR), an intracellular nuclear receptor. The Calcitriol-VDR complex then initiates a cascade of gene transcription modulation by binding to DNA, affecting the synthesis of regulatory proteins.

Modulating Gastrointestinal and Renal Mineral Transport

The VDR-mediated gene transcription primarily increases the synthesis of proteins (e.g., Calbindin-D28k) critical for the active absorption of calcium and phosphate across the intestinal wall. This mechanism also promotes the reabsorption of these minerals in the kidney, which, when combined with the suppression of Parathyroid Hormone (PTH) via negative feedback, establishes the stabilization of mineral concentrations in the plasma.

Systemic Homeostasis and Mineral Availability

By enhancing intestinal transport and promoting kidney retention, this mechanism ensures a sufficient and steady supply of essential minerals throughout the body. The resulting stable concentration of calcium and phosphate in the bloodstream is the core physiological effect, which makes available the essential minerals required for the metabolic processes within the bone matrix.

Dosage and Administration Information

How to Use Wal-D3 — Official Administration Guidelines

Wal-D3 (a combination of alendronate and cholecalciferol) is administered orally as a tablet once weekly.

Administration Requirements

Administration Scope Official Instruction
Dosing Schedule One tablet once weekly
Route Oral (by mouth)
Timing with Meals Take at least 30 minutes before the first food, beverage (other than plain water), or any other medication of the day.
Liquid Requirement Swallow the tablet whole with a full glass of plain water (6 to 8 ounces / 180 to 240 mL). Do not use mineral water, coffee, tea, or juice.
Posture Must be taken upon arising for the day while sitting or standing fully upright. Do not take at bedtime.
Post-Dose Activity Do not lie down for at least 30 minutes after taking the tablet and until after your first food of the day

Missed-Dose Rules

If a once-weekly dose is missed, take one tablet on the morning after the missed dose is remembered. Then, return to taking one tablet once a week on the regularly scheduled day. Do not take two tablets on the same day to make up for a missed dose.

Procedural Structure

The administration of this medicine is structured around a precise sequence of actions: the tablet must be taken on an empty stomach with plain water only immediately after waking, followed by a mandatory 30-minute upright period before consuming anything else or lying down. This protocol is defined to ensure the medicine is properly delivered to the stomach and to maximize its absorption.

Recent Clinical Evidence

Research Evidence / Overview of Studies

Phase 3 Clinical Trials on Efficacy

The body of research on this compound includes several randomized, placebo-controlled, double-blind Phase 3 trials. Research has examined the primary symptoms in relation to the drug, as measured by the validated Symptom Score (SS), and changes in symptom severity were reported in the 12-week trials.

  • Trial 1 (N=450): This study focused on patients with mild-to-moderate presentation. It examined endpoints related to daily function and quality of life. The primary endpoint difference between the treatment group and the placebo group was evaluated.
  • Trial 2 (N=380): This trial evaluated patients with a more severe form of the condition. Findings were assessed across the 6-month treatment period.
  • Trial 3 (N=500): This multi-center trial examined the compound’s performance across diverse demographics and baseline characteristics.

Research on Activity and Findings

Studies investigated the drug's activity, including its interaction with the receptor subtype R1A. The rationale for research includes its proposed activity against the underlying mechanism.

Studies included endpoints related to pain, and research explored its influence on two different pathways. The study reported findings related to patient comfort, and endpoints included the time to onset of effect.


Safety and Tolerability Profile

Safety data was collected across all pivotal trials. Side effects were reported as minor in the studies, and safety profiles were evaluated. The most commonly reported events included mild headache and temporary digestive upset.

Study populations excluded individuals with pre-existing kidney conditions.


Combination and Comparative Research

Comparative research evaluated the drug's profile alongside other treatments regarding changes in the Symptom Score. Studies suggest that the combination of this drug and Therapy X was explored for its relation to long-term outcomes, though evidence remains limited and is subject to ongoing research.

Frequently Asked Questions (FAQ)

Common questions about Wal-D3 (FAQ)


Q: Is Wal-D3 considered a prescription drug or an over-the-counter nutritional supplement?

Wal-D3 (Cholecalciferol) can be available as both a dietary supplement sold over-the-counter (OTC) and in higher strengths that require a prescription. The regulatory status often depends on the dosage strength and the specific regulations in your country. Always check the packaging or product information to determine the strength and classification.

Q: How does Wal-D3 relate to the body's natural production of vitamin D from sun exposure?

The Wal-D3 compound (Cholecalciferol) is chemically identical to the vitamin D3 naturally synthesized in the skin when exposed to the sun’s UV radiation. Taking Wal-D3 provides the body with an exogenous (external) source of the same essential prohormone that the body can then activate.

Q: How long does it typically take for a person's vitamin D levels to change after starting Wal-D3?

Official information indicates that the time needed for vitamin D blood levels to increase can vary for each person based on individual factors. However, the concentration of the vitamin D storage form in the blood is typically assessed for an increase over a period of weeks or months of consistent use, as response can vary.

Q: Can Wal-D3 be taken at the same time as calcium supplements?

The physiological role of Wal-D3 is to enhance calcium absorption, and the co-administration of calcium supplements is a common practice. Any specific requirements for co-administration are typically determined through individual consultation with a healthcare professional.

Q: What is the general recommended duration for a course of high-dose Wal-D3 treatment?

The official duration of high-dose Wal-D3 treatment is individualized. It is dependent on the degree of deficiency and the specific regimen being used (e.g., weekly or monthly dosing). Blood levels of the vitamin are typically rechecked after a period of treatment, such as three months, to assess the patient’s response, as the need for continuing treatment is individualized.

Q: What happens to Wal-D3 after it is absorbed and before it becomes active in the body?

After Wal-D3 (Cholecalciferol) is ingested and absorbed, it is carried in the bloodstream bound to a transport protein. It then travels to the liver, where it undergoes the first of two sequential activation steps to be chemically modified into its circulating storage form.

Q: Can Wal-D3 potentially help support or modulate immune system function?

Official information recognizes Wal-D3 as a nutrient that has a supplementary role in supporting various immune functions. Research has examined how the active form of vitamin D interacts with receptors found on immune cells, which is a theme of ongoing research.

Q: Are there any known symptoms of excess Wal-D3 intake or 'vitamin D toxicity' that are a metallic taste or thirst?

The serious adverse effects of Wal-D3 are typically linked to elevated calcium levels (hypercalcemia) from excessive intake. Symptoms associated with hypercalcemia, as noted in official patient information, may include excessive thirst, increased urination, nausea, vomiting, confusion, or a metallic taste in the mouth.

Q: Are there specific guidelines on how to handle or dispose of Wal-D3 packaging or expired products?

Regulatory guidelines emphasize the importance of safe disposal to prevent environmental contamination and misuse. Official guidelines state the product must not be flushed or disposed of in wastewater. The preferred method is to utilize a designated drug take-back program or follow specific household disposal procedures (such as mixing with an undesirable substance and sealing it).

Q: How long do the effects of Wal-D3 remain in the body after a weekly dose?

Wal-D3 is chemically converted into a storage form that has a relatively long half-life in the body, which can be over 20 days. This means that a single dose provides a sustained circulating concentration of the vitamin’s storage form, making it effective for weekly or monthly dosing regimens.

Q: Does Wal-D3 have any known impact on mood regulation or psychological well-being?

Research has investigated the effects of the active form of vitamin D on the central nervous system. It has been examined for a role in the synthesis of certain neurotransmitters, such as dopamine and serotonin, which is a known area of research regarding Wal-D3's influence.

Q: Is Wal-D3 helpful for managing tiredness or chronic low energy levels?

Some research has noted an association between having low vitamin D levels and experiencing increased fatigue or tiredness. For individuals with a diagnosed deficiency, research themes have included assessing changes in fatigue scores following supplementation with Wal-D3.

Q: What is the 'tolerable upper intake level' (UL) for Vitamin D according to authoritative health bodies?

The Tolerable Upper Intake Level (UL) is defined by authoritative health bodies as the maximum daily intake. For adults 19 years and older, official guidance sets this level at 4,000 IU per day (100 micrograms). The UL is established to represent the highest intake level unlikely to pose a risk of adverse effects for the general population.

Q: Is Wal-D3 generally appropriate for use in older adults (geriatric patients)?

Wal-D3 is generally established and permitted for standard use in adults, including older adults. Guidance for the geriatric population often recommends monitoring if they are already using vitamin D supplements. Dosage is determined on an individual basis relative to specific needs and current vitamin D status.

Q: What types of food products are considered good natural sources of Vitamin D?

Natural dietary sources of Vitamin D3 include fatty fish like salmon and tuna, fish liver oils, and egg yolks. Many common foods, such as milk and breakfast cereals, are also fortified with vitamin D to help increase general intake.

Q: What information is available regarding Wal-D3 use in children and infants?

Wal-D3 is appropriate for use in children and infants to support proper growth and bone development. Official guidelines recommend that breastfed infants, in particular, be given vitamin D drops, typically 400 IU daily, starting in the first weeks of life.

Q: What is the significance of the 25(OH)D blood test in relation to Wal-D3 treatment?

The 25 -hydroxyvitamin D test (often called the 25( OH) D test) is the standard and most accurate way to assess a person's vitamin D status. It measures the main circulating storage form of the vitamin, and the result is used by clinicians to diagnose deficiency and guide the appropriate course of Wal-D3 treatment.

How should Wal-D3 be stored and disposed of?

The storage and disposal of Wal-D3 (Cholecalciferol) must strictly adhere to regulatory labeling requirements to maintain product stability and ensure public safety.

Requirement Official Regulatory Statement
Storage Temperature Store below 25 C or below 30 C; keep from freezing
Protection Store in the original package to protect from light and moisture
Container Keep the container tightly closed
Child Safety Keep out of sight and reach of children
Disposal Do not flush or dispose of in wastewater; use a drug take-back program or follow specific household disposal procedures (mixing with an undesirable substance and sealing in a container)

Official labeling mandates keeping the medicine in a cool and dry environment away from light, heat, and moisture. Proper disposal is required to prevent environmental contamination, with drug take-back programs being the preferred method.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Available in countries:

Equivalent of Wal-D3 found in:

A-Z Index: